PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with metastatic prostate cancer

Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with  metastatic prostate cancer
2024-07-08
(Press-News.org)

Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with  metastatic prostate cancer

 

Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of therapy response and resistance in patients with metastatic disease.

 

Published today in the journal Cancer Cell, results of a VHIO-led study show that a newly developed liquid biopsy-based approach can monitor tumor gene expression through RNA contained in circulating extracellular vesicles secreted by cancer cells.  

These findings could help to predict response to treatment, contribute to the development of new combination strategies to combat mechanisms of acquired drug resistance, and expand the opportunities to study cancer from liquid biopsies.

 

This work was mainly supported by funding received from the ”la Caixa” Foundation, FERO Foundation, and CRIS Cancer Foundation.

 

Published today in Cancer Cell (1), results of a study directed by Joaquin Mateo, Head of the Vall d’Hebron Institute of Oncology’s (VHIO) Prostate Cancer Translational Research Group, show that DNA/RNA material contained in circulating extracellular vesicles secreted into the blood stream by tumor cells, captures cancer genomics and transcriptomic evolution in patients with metastatic prostate cancer.

 

“Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course of disease,” says Joaquin Mateo, Medical Oncologist at the Vall d’Hebron University Hospital (HUVH), Vall d’Hebron Campus, and Corresponding Author of this VHIO-led study.  

 

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world’s second most frequent cancer and the fifth leading cause of cancer death among men in 2022. Mortality rates have decreased in most high income-countries since the mid-1990’s, likely reflecting advancements in treatments and earlier detection (2). Nowadays, the majority of prostate cancer patients diagnosed at an early stage can be cured through cancer surgery, radiotherapy or brachytherapy with or without hormone therapy.

 

In metastatic prostate cancer, novel systemic therapies, hormone-based treatments or chemotherapy have improved the survival of patients in this setting, but responses to treatment are highly heterogeneous, and tumors eventually develop cancer drug resistance.

 

“The development of new tools and the identification of novel biomarkers of response and resistance are key to guiding and adapting treatment strategies based on the monitoring of tumor evolution in individual patients,” adds Mateo.

 

Circulating extracellular vesicles

 

Under normal conditions, extracellular vesicles are conduits of intercellular communication and mediators of various biological processes. These heterogeneous particles contain proteins, lipids, metabolites, RNA and DNA as cargo. Extracellular vesicles produced by tumor cells promote cancer cell communication, and their protein load composition plays a key role in tumor progression, immune regulation, and metastasis.

 

“However, the potential of tumor extracellular vesicles as a source of clinically relevant DNA and RNA biomarkers remains largely unexplored. We have now developed a new liquid biopsy application for the analysis of circulating vesicles secreted by cancer cells and performed multi-omic profiling for the genomic and transcriptomic characterization of these tumors,” explains Irene Casanova, an Associate Investigator of Joaquin Mateo’s group and First Author of this Report article.

 

The transcriptomic and genomic profiling of metastatic prostate cancer in liquid biopsy

 

The investigators analyzed liquid biopsies—collected by plasma series sampling throughout the course of disease—of a retrospective cohort of 53 metastatic castration-resistant prostate cancer patients who received treatment with hormone therapy or chemotherapy. They studied DNA and RNA in circulating extracellular vesicles, results of which confirm that these vesicles contain tumor-derived genetic material that can help to identify specific mutations present in tumor cells and forecast the evolution of disease.

 

Using a newly developed liquid biopsy technique, findings demonstrate that DNA and RNA contained in circulating vesicles reflect the genomic and transcriptomic features in metastatic prostate cancer. Furthermore, results of mRNA expression analysis—performed for the first time in extracellular vesicles in liquid biopsies—enables the monitoring of on-therapy changes in these tumors.

 

“The study of transcriptomic features by liquid biopsy in clinical samples has mostly been unsuccessful due to the rapid degradation of RNA when it is not shielded by the cell membrane. Our study shows that tumor mRNA encapsulated in circulating extracellular vesicles is protected and therefore represents a  promising source of clinically relevant information,” adds Casanova.

 

Carried out in collaboration with colleagues at the Principe Felipe Research Institute (CIPF) in Valencia, and the Spanish National Cancer Research Center (CNIO), Madrid, Spain, the researchers have characterized the transcriptomic profile of these tumors that could serve as a biomarker of response or resistance to therapy. Their findings could also expand the opportunities to study cancer from minimally invasive liquid biopsies.

 

“Drug resistance remains a major challenge in more effectively treating cancer. Adaptive mechanisms of resistance occur more rapidly and dynamically than mutations driving acquired resistance. Monitoring these changes as they occur by liquid biopsy will enable real‐time clinical decision‐making and the selection of adaptive treatments to help combat evolving tumor dynamics earlier,” concludes Joaquin Mateo.

 

This work was funded by a ”la Caixa” Foundation Junior Leader Fellowship to Irene Casanova and a grant from the FERO Foundation and Ramon Areces Foundation to Joaquin Mateo.  VHIO’s Prostate Cancer Translational Research Group is also supported by funding received from the CRIS Cancer Foundation. 

END


[Attachments] See images for this press release:
Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with  metastatic prostate cancer

ELSE PRESS RELEASES FROM THIS DATE:

Schrag studying history Of Dulles Corridor Metrorail Project

2024-07-08
Zachary Schrag, Professor, History and Art History, College of Humanities and Social Sciences (CHSS), received funding for the project: “Rail Against Sprawl: A History of the Dulles Corridor Metrorail Project.”  Schrag said, “I am writing the history of the Dulles Corridor Metrorail Project, among the nation’s most ambitious efforts to reshape daily transportation choices. After decades of planning and construction, the project was completed in 2022, extending the Washington ...

Study identifies racial and gender disparities in youth psychiatric emergency department boarding

2024-07-08
A new study led by researchers at McLean Hospital and Harvard Medical School, in collaboration with researchers from Massachusetts General Hospital and Cambridge Health Alliance, has uncovered concerning disparities in boarding rates of children and adolescents with severe mental health symptoms in emergency departments. When reviewing more than 4,900 boarding episodes of youth under 17 years old in Massachusetts over an 18-month period, the researchers found there were numerous racial and gender disparities: Black youth were less likely to be admitted to inpatient psychiatric care than White youth.  Additionally, transgender and nonbinary youth experienced ...

Raw milk is risky, but airborne transmission of H5N1 from cow's milk is inefficient in mammals

Raw milk is risky, but airborne transmission of H5N1 from cows milk is inefficient in mammals
2024-07-08
While H5N1 avian influenza virus taken from infected cow’s milk makes mice and ferrets sick when dripped into their noses, airborne transmission of the virus between ferrets — a common model for human transmission — appears to be limited. These and other new findings about the strain of H5N1 circulating among North American dairy cattle this year come from a set of laboratory experiments led by University of Wisconsin–Madison researchers, reported today in the journal Nature. Together, they suggest that exposure to raw milk infected with the currently circulating virus poses a real risk of infecting humans, but that the virus may not ...

Features of H5N1 influenza viruses in dairy cows may facilitate infection, transmission in mammals

Features of H5N1 influenza viruses in dairy cows may facilitate infection, transmission in mammals
2024-07-08
WHAT: A series of experiments with highly pathogenic H5N1 avian influenza (HPAI H5N1) viruses circulating in infected U.S. dairy cattle found that viruses derived from lactating dairy cattle induced severe disease in mice and ferrets when administered via intranasal inoculation. The virus from the H5N1-infected cows bound to both avian (bird) and human-type cellular receptors, but, importantly, did not transmit efficiently among ferrets exposed via respiratory droplets. The findings, published in Nature, suggest that bovine (cow) ...

Scientists discover how to improve vaccine responses to potentially deadly bacterium

2024-07-08
Researchers from Trinity College Dublin have taken a leap forward in understanding how we might fight back against the potentially deadly MRSA bacterium. They have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during the delivery of a vaccine improves the ability of the vaccine to protect against infection. The bacterium Staphylococcus aureus is one of the leading causes of community- and hospital-acquired bacterial infection, and is associated with over one million deaths worldwide each year. Unfortunately, antibiotics are becoming increasingly less effective against this bacterium with the antibiotic-resistant ...

Sauer receives funding for project studying tunable RF atomic magnetometer as an electrically small receiver

2024-07-08
Sauer Receives Funding For Project Studying Tunable RF Atomic Magnetometer As An Electrically Small Receiver Karen Sauer, Professor, Physics and Astronomy, College of Science, received funding for the project: “Tunable RF Atomic Magnetometer as an Electrically Small Receiver.” Sauer will complete work for this project in three phases. In Phase 1, she will focus on developing and investigating novel bias-field control based on fully atom-based measurements as well as testing the performance ...

Study highlights the importance of infection prevention after CAR-T cell therapy

2024-07-08
RESEARCH SUMMARY Study highlights the importance of infection prevention after CAR-T cell therapy Study Title: A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy  Publication: Nature Medicine Dana-Farber Cancer Institute authors: David M. Cordas dos Santos, MD, Irene M. Ghobrial, MD, Jean-Baptiste Alberge, PhD Summary: Researchers at Dana-Farber Cancer Institute, in collaboration with colleagues from Memorial Sloan Kettering Cancer Center in New York (Dr. Kai Rejeski) and the LMU Hospital in Munich, Germany (Dr. Tobias Tix), have found ...

New gold standard survey shows alarmingly high rate of sexual exploitation across the United States

2024-07-08
A revised version of the Sexual Experiences Survey – Victimization (SES-V), the gold standard measurement of sexual exploitation designed for adults over age 18, has been released in a special issue of the Journal of Sex Research. As the first revision since 2007, the new SES-V is an interdisciplinary collaboration among experts across more than 10 U.S. universities and the Kinsey Institute, led and coordinated by Dr. Mary Koss from the University of Arizona. It adopts more inclusive language and ...

Stench of a gas giant? Nearby exoplanet reeks of rotten eggs. And that’s a good thing

Stench of a gas giant? Nearby exoplanet reeks of rotten eggs. And that’s a good thing
2024-07-08
An exoplanet infamous for its deadly weather has been hiding another bizarre feature—it reeks of rotten eggs, according to a new Johns Hopkins University study of data from the James Webb Space Telescope. The atmosphere of HD 189733 b,  a Jupiter-sized gas giant, has trace amounts of hydrogen sulfide, a molecule that not only gives off a stench but also offers scientists new clues about how sulfur, a building block of planets, might influence the insides and atmospheres of gas worlds beyond the solar system. The findings are published today ...

Study backs RSV vaccine safety during pregnancy

2024-07-08
Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. Infants are particularly vulnerable to the virus which can cause a serious lower respiratory illness. The study published in JAMA Network Open on July 8 adds real-world evidence to the existing data from clinical trials about the safety of Pfizer’s Abrysvo vaccine. The researchers found that there ...

LAST 30 PRESS RELEASES:

Impact of pollutants on pollinators, and how neural circuits adapt to temperature changes

Researchers seek to improve advanced pain management using AI for drug discovery

‘Neutron Nexus’ brings universities, ORNL together to advance science

Early release from NEJM Evidence

UMass Amherst astronomer leads science team helping to develop billion-dollar NASA satellite mission concept

Cultivating global engagement in bioengineering education to train students skills in biomedical device design and innovation

Life on Earth was more diverse than classical theory suggests 800 million years ago, a Brazilian study shows

International clean energy initiative launches global biomass resource assessment

How much do avoidable deaths impact the economy?

Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans

New therapeutic target for cardiac arrhythmias emerges

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

Moffitt study unveils the role of gamma-delta T cells in cancer immunology

Drier winter habitat impacts songbirds’ ability to survive migration

Donors enable 445 TPDA awards to Neuroscience 2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

Are auditory magic tricks possible for a blind audience?

Research points to potential new treatment for aggressive prostate cancer subtype

Studies examine growing US mental health safety net

Social risk factor domains and preventive care services in US adults

Online medication abortion direct-to-patient fulfillment before and after the Dobbs v Jackson decision

Black, Hispanic, and American Indian adolescents likelier than white adolescents to be tested for drugs, alcohol at pediatric trauma centers

Pterosaurs needed feet on the ground to become giants

Scientists uncover auditory “sixth sense” in geckos

Almost half of persons who inject drugs (PWID) with endocarditis will die within five years; women are disproportionately affected

Experimental blood test improves early detection of pancreatic cancer

Groundbreaking wastewater treatment research led by Oxford Brookes targets global challenge of toxic ‘forever chemicals’

Jefferson Health awarded $2.4 million in PCORI funding

Cilta-cel found highly effective in first real-world study

Unleashing the power of generative AI on smart collaborative innovation network platform to empower research and technology innovation

[Press-News.org] Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with metastatic prostate cancer